Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09PJK
|
||||
| Former ID |
DIB000396
|
||||
| Drug Name |
ACK-1 inhibitors
|
||||
| Synonyms |
ACK-1 inhibitors (cancer); ACK-1 inhibitors (cancer), Amgen; Activated Cdc42Hs-associated tyrosine kinase-1 inhibitors (cancer), Amgen
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [552118] | ||
| Company |
Amgen Inc
|
||||
| Canonical SMILES |
C1CCCN1CCOc1c(cc(cc1)Nc1ncc2c(n1)n(nc2Nc1c(cccc1C)C)CCC<br />(C)(C)OC)F
|
||||
| Target and Pathway | |||||
| Target(s) | Activated CDC42 kinase 1 | Target Info | Inhibitor | [543581] | |
| NetPath Pathway | TSH Signaling Pathway | ||||
| Pathway Interaction Database | CDC42 signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.